SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001689375-23-000036
Filing Date
2023-05-10
Accepted
2023-05-10 07:16:32
Documents
15
Period of Report
2023-05-10
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K trda-20230510.htm   iXBRL 8-K 40432
2 EX-99.1 trda20230510-pr.htm EX-99.1 46094
7 GRAPHIC image_0a.jpg GRAPHIC 30141
  Complete submission text file 0001689375-23-000036.txt   319674

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT trda-20230510.xsd EX-101.SCH 2165
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT trda-20230510_def.xml EX-101.DEF 16049
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT trda-20230510_lab.xml EX-101.LAB 30952
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT trda-20230510_pre.xml EX-101.PRE 16770
9 EXTRACTED XBRL INSTANCE DOCUMENT trda-20230510_htm.xml XML 14474
Mailing Address 6 TIDE STREET BOSTON MA 02210
Business Address 6 TIDE STREET BOSTON MA 02210 857-305-1825
Entrada Therapeutics, Inc. (Filer) CIK: 0001689375 (see all company filings)

IRS No.: 813983399 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40969 | Film No.: 23904324
SIC: 2834 Pharmaceutical Preparations